Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma
- PMID: 30879178
- DOI: 10.1007/s12094-019-02076-0
Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma
Abstract
Background: Central lymph node metastasis (LNM) in papillary thyroid carcinoma (PTC) is common. But the association between primary tumor characteristics and specific features of metastatic lymph nodes in PTC has not been fully identified. Determining risk factors for LNM may help surgeons determine rational extent of lymph node dissection.
Methods: Data from 432 patients who underwent thyroidectomy with cervical lymph node dissection for PTC were retrospectively analyzed. The relationships between LNM to central compartment or lateral compartment and clinicopathologic factors were analyzed. Cox regression model was used to determine the risk factors for recurrence-free survival (RFS).
Results: Central lymph node metastasis (CLNM) and lateral lymph node metastasis (LLNM) were found in 216 (50.0%) and 65 (15.0%) patients, respectively. In the multivariate analysis for CLNM, patients < 45 years of age (OR 2.037, 95% CI 1.388-2.988, P < 0.001), extrathyroidal invasion (OR: 2.144, 95% CI 0.824-5.457, P = 0.011), vascular invasion (OR 13.817, 95% CI 1.694-112.693, P = 0.014), LLNM (OR 2.851, 95% CI 1.196-6.797, P = 0.014) and TNM Stage III-IV (OR 465.307, 95% CI 113.903-1900.826, P < 0.001) were independent predictors for high prevalence of CLNM. In the multivariate analysis for LLNM, tumor size more than 1cm (OR 3.474, 95% CI 1.728-6.985, P < 0.001) and CLNM (OR 5.532, 95% CI 2.679-11.425, P < 0.001) were independent predictors for high prevalence of LLNM. Moreover, tumor with T3-T4 stage, extrathyroidal invasion and CLNM were the significant factors related to the RFS.
Conclusion: For patients with pre-operative risk factors of LNM, an accurate preoperative evaluation of central compartment or lateral compartment is needed to find suspicious lymph nodes. And prophylactic lymph node dissection should be performed in patients with high risk of CLNM. Moreover, we suggest performing close follow-up for patients with high risk of RFS.
Keywords: Extrathyroidal invasion; Lymph node metastases; Papillary thyroid carcinoma; Recurrence; Recurrence-free survival; Vascular invasion.
Similar articles
-
Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.BMC Cancer. 2019 Jun 25;19(1):622. doi: 10.1186/s12885-019-5835-6. BMC Cancer. 2019. PMID: 31238891 Free PMC article.
-
Nomogram for predicting the risk of cervical lymph node metastases and recurrence in papillary thyroid carcinoma based on the thyroid differentiation score system and clinical characteristics.BMC Endocr Disord. 2025 Feb 13;25(1):39. doi: 10.1186/s12902-025-01867-7. BMC Endocr Disord. 2025. PMID: 39939864 Free PMC article.
-
Significance of multifocality in papillary thyroid carcinoma.Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1820-1828. doi: 10.1016/j.ejso.2020.06.015. Epub 2020 Jun 19. Eur J Surg Oncol. 2020. PMID: 32732090
-
Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.Int J Surg. 2018 Nov;59:90-98. doi: 10.1016/j.ijsu.2018.09.004. Epub 2018 Oct 17. Int J Surg. 2018. PMID: 30342280 Review.
-
Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: Diagnosis of central and lateral compartment nodal metastases.Eur J Radiol. 2019 Mar;112:14-21. doi: 10.1016/j.ejrad.2019.01.006. Epub 2019 Jan 7. Eur J Radiol. 2019. PMID: 30777203 Review.
Cited by
-
Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma.Int J Endocrinol. 2022 Feb 28;2022:3534783. doi: 10.1155/2022/3534783. eCollection 2022. Int J Endocrinol. 2022. PMID: 35265124 Free PMC article.
-
Pretreatment level of circulating tumor cells is associated with lymph node metastasis in papillary thyroid carcinoma patients with ≤ 55 years old.World J Surg Oncol. 2025 Jan 29;23(1):29. doi: 10.1186/s12957-025-03670-z. World J Surg Oncol. 2025. PMID: 39881336 Free PMC article.
-
Fasting serum glucose and lymph node metastasis in non-diabetic PTC patients: a 10-Year multicenter retrospective study.J Cancer. 2022 May 20;13(8):2673-2682. doi: 10.7150/jca.71514. eCollection 2022. J Cancer. 2022. PMID: 35711846 Free PMC article.
-
PTC-MAS: A Deep Learning-Based Preoperative Automatic Assessment of Lymph Node Metastasis in Primary Thyroid Cancer.Diagnostics (Basel). 2023 May 12;13(10):1723. doi: 10.3390/diagnostics13101723. Diagnostics (Basel). 2023. PMID: 37238205 Free PMC article.
-
Completion Total Thyroidectomy Is Not Necessary for Papillary Thyroid Microcarcinoma with Occult Central Lymph Node Metastasis: A Long-Term Serial Follow-Up.Cancers (Basel). 2020 Oct 18;12(10):3032. doi: 10.3390/cancers12103032. Cancers (Basel). 2020. PMID: 33081050 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical